Is Hair Loss a Side Effect of Wegovy?

Does Wegovy directly cause hair to fall out?

Short answer: the current evidence says no. Wegovy's clinical trials, including the large STEP 1 study published in the New England Journal of Medicine, did not identify alopecia or hair thinning as a treatment-related adverse event at a meaningful rate. Semaglutide does not appear to act on the hair follicle directly; there is no known pharmacological reason it would.

The confusion is understandable. People starting Wegovy are losing weight at a faster rate than they have before, and within a few months some notice their hair shedding more than usual. It feels like a side effect of the injection (the timing stacks up) so it gets labelled as one. That instinct is natural, but the mechanism points elsewhere.

If you are seeing increased shedding after starting Wegovy, the most likely explanation is a condition called telogen effluvium, not the medicine itself. Keeping that distinction clear is genuinely useful, because the management is different.

What is telogen effluvium and why does rapid weight loss trigger it?

Hair grows in cycles: a growth phase (anagen), a transition phase, and a resting phase (telogen) that ends with the strand falling out naturally. Physical or metabolic stress can push a disproportionate number of follicles into the telogen phase simultaneously. Two to four months later, those resting hairs shed at once, producing noticeably more hair in the shower or on the pillow.

Significant calorie restriction is a well-recognised trigger. The body interprets a sharp reduction in energy intake as a physiological stressor, and hair growth is not high on its priority list when resources are tight. Weight-loss surgery, very low-calorie diets and rapid unintentional weight loss can all produce the same pattern. Wegovy, by substantially reducing appetite, can create the same conditions — especially in the early months when weight is coming off quickly.

The pattern almost always resolves once weight stabilises. Hair density returns gradually over several months. Explore the full Wegovy side-effect profile if you want context on how this fits alongside the more common GI effects that do appear in the prescribing information.

Can anything reduce the shedding while on treatment?

Nutritional adequacy is the most evidence-adjacent lever. Protein is the main structural building block for hair, and when appetite drops sharply it is often the first macronutrient people under-eat. Aiming to maintain adequate protein intake throughout treatment is practical advice most prescribers would give. Iron, zinc, biotin and ferritin levels are worth checking with a GP if shedding is persistent or severe, as our page on Wegovy side effects and hair loss covers why deficiencies in any of these are independent contributors to hair thinning.

Crash-dieting on top of the appetite suppression Wegovy produces is counterproductive for hair health. A modest calorie reduction alongside the medicine, with protein prioritised, is a more sensible pattern than eating as little as possible. A dietitian can help build a plan that supports both weight loss and nutritional adequacy.

There is no strong evidence that any topical product specifically prevents telogen effluvium caused by weight loss. Patience, and adequate nutrition, is currently the most honest advice available. Learn more about what happens to hair after Wegovy treatment as weight stabilises.

When does hair shedding need medical attention?

Most telogen effluvium following weight loss is self-limiting and does not require treatment beyond nutritional attention. There are signs, however, that warrant a proper clinical assessment rather than watchful waiting.

See a GP if: shedding is severe or continues beyond six months without improvement; you notice patchy loss or bald spots rather than diffuse thinning; hair loss is accompanied by other symptoms such as fatigue, cold intolerance or unexplained skin changes (which can point to thyroid dysfunction); or you have any reason to suspect a nutritional deficiency is involved.

Separately, for any suspected side effect related to Wegovy or any medicine, you can report it through the MHRA's Yellow Card scheme. That reporting is open to patients as well as healthcare professionals and helps the MHRA monitor the real-world safety profile of medicines over time. If you have broader questions about how Wegovy's side effects are monitored, our clinical team is available through aftercare seven days a week.

Wegovy is a prescription-only medicine. A GPhC-registered prescriber at nume (sorry, at nume) reviews every consultation individually, including discussing side effects relevant to your medical history, before any treatment is issued. If questions about hair shedding or other effects come up during your free consultation, they belong in that conversation.